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Body weight loss strategies include combination of nutrition consultation, 
regular exercise, drug prescription, invasive intervention and/or non-invasive 
intervention. A non-invasive intervention such as transdermal administration of active 
ingredients helps in reducing localized subcutaneous adipose tissue through lipolysis. 
Zingiber officinale (ZO) and Zingiber zerumbet (ZZ) belong to the Zingiberaceae 
family and both have been discovered to possess lipolysis activity. An efficient drug 
delivery system is required to encapsulate ZO and ZZ, and deliver these substances up 
to the subcutaneous skin layer. In this study, ZO and ZZ oil were successfully 
encapsulated in nanostructured lipid carrier (NLC) using hot homogenization 
technique followed by ultrasonication. D-optimal mixture design was used to optimize 
the NLC in which the composition of ZO and ZZ oil, solid lipid, and liquid lipid were 
the independent variables, while particle size, polydispersity index (PDI), zeta 
potential, and encapsulation efficiency were the dependent variables. From the study, 
the optimum formulation for NLC-ZO was 3.6% ZO oil, 1.4% glyceryl monostearate, 
and 5.0% virgin coconut oil, and the NLC-ZO obtained had the following properties: 
90.7 nm particle size, 0.15 PDI, -45.7 mV zeta potential and 88.8% encapsulation 
efficiency. The optimum NLC-ZZ formulation was 3.7% ZZ oil, 1.3% glyceryl 
monostearate, and 5.0% virgin coconut oil, and the NLC-ZZ obtained had the 
following properties: 91.0 nm particle size, 0.17 PDI, -40.9 mV zeta potential and 
94.4% encapsulation efficiency. Morphology study revealed the spherical shape of 
NLC-ZO and NLC-ZZ, and the particle size obtained through transmission electron 
microscope conformed with the size measured through dynamic light scattering 
technique. Thermogram profile of NLC showed incorporation of ZO and ZZ into NLC 
lowered the melting temperature of lipid mixture, thus producing a less ordered 
crystalline structure of NLC to accommodate the active ingredients. Fourier transform 
infrared spectroscopy analysis demonstrated an interaction existed between ZO/ZZ 
and the NLC system. In vitro penetration study using Strat-M® membrane and freshly 
excised rat skin showed NLC-ZO and NLC-ZZ had higher penetration flux compared 
to free ZO and ZZ. The release of ZO from NLC-ZO followed Korsmeyer-Peppas 
model, and the release of ZZ from NLC-ZZ followed zero order kinetic model. 90-day 
storage stability study showed no significant changes for both NLC-ZO and NLC-ZZ 
in terms of particle size, PDI and zeta potential. In vitro lipolysis study revealed the 
potential of NLC-ZO and NLC-ZZ as anti-obesity agents as they stimulated the release 
of glycerol in 3T3-L1 adipocytes cells. In vivo NLC distribution in female Sprague-
Dawley rats showed penetration deep into the dermis layer after 12 h of application. 
Free fatty acid release was detected when the rats were treated with NLC-ZO and 
NLC-ZZ for 3 h. This study demonstrated that ZO and ZZ were successfully 
encapsulated in NLC and the nanoparticles were effectively utilized to enhance dermis 








Strategi penurunan berat badan meliputi kombinasi perundingan pemakanan, 
kekerapan bersenam, preskripsi ubat-ubatan, campur tangan invasif dan/atau campur 
tangan tidak-invasif. Campur tangan tidak invasif seperti pengurusan bahan aktif 
secara transdermal membantu mengurangkan tisu adiposa subkutanus setempat 
menerusi lipolisis. Zingiber officinale (ZO) dan Zingiber zerumbet (ZZ) adalah 
daripada keluarga Zingiberaceae dan kedua-duanya ditemui mempunyai aktiviti 
lipolisis. Sistem penyampaian ubat yang cekap diperlukan untuk merangkum ZO dan 
ZZ dan menghantar bahan ini sehingga ke lapisan subkutanus kulit. Dalam kajian ini, 
minyak ZO dan minyak ZZ telah berjaya dimuatkan dalam pembawa lipid berstruktur 
nano (NLC) menggunakan teknik homogenisasi panas diikuti ultrasonik. Reka bentuk 
campuran D-optimal telah digunakan untuk mengoptimumkan NLC di mana 
komposisi minyak ZO dan ZZ, lipid pepejal dan lipid cecair sebagai pembolehubah 
tidak bersandar, manakala saiz zarah, indeks poliserakan (PDI), potensi zeta, dan 
kecekapan enkapsulasi sebagai pembolehubah bersandar. Dari kajian ini, rumusan 
yang optimum untuk NLC-ZO adalah 3.6% minyak ZO, 1.4% gliseril monostiarat, dan 
5.0% minyak kelapa dara, dan NLC-ZO yang dihasilkan mempunyai sifat-sifat 
berikut: saiz zarah 90.7 nm, PDI 0.15, keupayaan zeta -45.7 mV, dan kecekapan 
pengkapsulan 88.8%. Rumusan NLC-ZZ yang optimum adalah 3.7% minyak ZZ, 
1.3% gliseril monostiarat, dan 5.0% minyak kelapa dara, dan NLC-ZZ yang dihasilkan 
mempunyai sifat berikut: saiz zarah 91.0 nm, PDI 0.17, keupayaan zeta -40.9 mV dan 
kecekapan pengkapsulan 94.4%. Kajian morfologi menunjukkan yang NLC-ZO dan 
NLC-ZZ berbentuk sfera, dan saiz zarah yang diperolehi melalui analisis mikroskop 
transmisi elektron mengesahkan saiz yang diukur melalui teknik penyelerakan cahaya 
dinamik. Profil termogram NLC menunjukkan penggabungan ZO dan ZZ ke dalam 
NLC telah menurunkan suhu lebur campuran lipid, sehingga menghasilkan struktur 
kristal NLC yang kurang teratur untuk menampung bahan-bahan aktif. Analisis 
spektroskopi inframerah transformasi Fourier menunjukkan interaksi antara sistem 
ZO/ZZ dan NLC. Kajian penembusan secara in vitro menggunakan membran Strat-
M® dan kulit tikus yang disiat segar menunjukkan NLC-ZO dan NLC-ZZ mempunyai 
fluks penembusan yang lebih tinggi berbanding ZO dan ZZ. Pelepasan ZO daripada 
NLC-ZO mengikuti model Korsmeyer-Peppas dan pelepasan ZZ daripada NLC-ZZ 
mengikuti model kinetik tertib sifar. Kestabilan penyimpanan selama 90 hari 
menunjukkan tiada perubahan ketara bagi NLC-ZO dan NLC-ZZ dari segi saiz zarah, 
PDI dan keupayaan zeta. Kajian lipolisis secara in vitro telah mendedahkan potensi 
NLC-ZO dan NLC-ZZ sebagai agen anti-obesiti yang meransang pembebasan gliserol 
dalam sel-sel adiposit 3T3-L1. Kajian penyebaran NLC secara in vivo pada tikus 
Sprague-Dawley betina telah menunjukkan penembusan sehingga ke lapisan dermis 
selepas 12 jam rawatan. Pembebasan asid lemak bebas telah dikesan apabila tikus 
dirawat dengan NLC-ZO dan NLC-ZZ selama 3 jam. Kajian ini menunjukkan bahawa 
ZO dan ZZ telah berjaya dirangkumkan dalam NLC dan zarah nano ini berkesan untuk 
meningkatkan penembusan sehingga ke lapisan dermis dan mendorong aktiviti 
lipolisis secara in vitro dan in vivo.  
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1.1 Research Background  
 
 
Obesity has reached epidemic proportions and is a significant contributor to 
the global burden of chronic disease and disability. Currently, nearly two billion adults 
worldwide are overweight, and at least 600 million of them are clinically obese (WHO, 
2016). Obesity often related to the appearance of excess fat or adiposities which may 
generate social distress, physiological embarrassment, affecting the quality of life and 
highlighting possible undetected metabolic disturbance. The modern lifestyle does 
take its toll on current generations, for instance, long working hours and less physical 
activities, as well as exposure to imbalanced high caloric diet. The imbalance of diet 
intake and energy expenditure are generating more obesity-prone individual. The 
excess of calories is naturally stored within adipocytes.  
 
 
White adipose tissues provide insulation and serve as useful energy depot. It 
also plays a vital role in maintaining an excellent endocrine equilibrium and actively 
contributes to the control of lipid and glucose metabolism. However, excessive adipose 
tissue distribution in human bodies does affect negatively to appearance and health 
state of an individual. The adiposities have a number of side effect including skin 
barrier alterations, sebaceous gland hyperactivity, apocrine and eccrine sweat glands 
hyperactivity, impaired lymphatic drainage leading to inflammation and fibrosis, 
altered collagen structure, impaired wound healing, and decreased microvascular 
homeostatic efficiency (Sparagvina et al., 2012).  
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To date, there are two types of obesity-treatment drugs available in the market 
which is orlistat and sibutramine. Both drugs treat obesity through the gastrointestinal 
route in which they reduce energy intake. However, due to the dissatisfaction of high 
costs and potentially hazardous side effects of these drugs, numerous researches have 
reported potential plant extracts which may be an excellent alternative strategy for the 
anti-obesity drug (Yun, 2010). Alternatively, various non-invasive techniques in 
reducing localized subcutaneous adipose tissue were reported safe and effective, for 
example, low-level laser therapy (LLLT), cryolipolysis, radio frequency (RF) and high 
intensity focused ultrasound (HIFU) (Kennedy et al., 2015). On the other hand, 
liposuction surgery has been reported as extremely effective in reducing adiposities 
although the post-procedural pain may cause discomfort (Hunstad et al., 2018). 
Reports by Greenway et al., (1995) and Sparagvina et al., (2012) have proved a 
reduction of weight through transdermal administration of drug which promotes 
lipolysis of fat cell under the skin.  
 
 
Subcutaneous adipose tissue constitutes the largest fat depot and altered 
distribution of subcutaneous fat may affect skin elasticity and cosmetically 
undesirable. Inefficient subcutaneous fat cell lipolysis also independently linked to 
long-term weight gain and disturbed glucose metabolism (Arner et al., 2018). It is well 
established that obesity is characterized by increased spontaneous (basal) but 
decreased hormone stimulated fat cell lipolysis. Major endogenous stimulators of 
lipolysis are catecholamines, which accelerates lipolysis after binding to beta-
adrenergic receptors and stimulates the production of cyclic AMP (cAMP). The cAMP 
production activates lipases that hydrolyze fat cell triglycerides into glycerol and fatty 
acids. The energy-rich fatty acids are oxidized for energy consumption in skeletal 
muscle, heart, and liver. Therefore, it is possible that variation in basal and/or 
stimulated adipocyte lipolysis may impact weight development. On the other hand, 
reports by Roure et al., (2011) showed the potential of caffeine and forskolin as active 
ingredients which stimulated lipolysis through adenylate cyclase activation and inhibit 
phosphodiesterase. The lipolysis activity was measured from glycerol release after 





The treatment of obesity is commonly done together with regulation of diet and 
regular exercise. There are rising needs to manage obesity with low cost, high efficacy 
and give very fewer side effects. Oral drug delivery poses multiple challenges such as 
relatively low uptake and low bioavailability which is due to the absorption of the drug 
in digestive system and enters the hepatic portal system. As the liver metabolizes the 
drug, only a small amount of active drug emerges from the liver to the rest of the 
circulatory system. Therefore, transdermal drug delivery is a preferred candidate due 
to reduced systemic effect as compared to oral and parenteral drug delivery. However, 
very scarce data available on anti-obesity treatment strategy which utilizing local 
plants for transdermal drug delivery.    
 
 
Zingiber officinale (ginger), ZO and Zingiber zerumbet (pinecone ginger), ZZ 
are common spices used around the world and long been used in traditional medicine 
as a cure for ailments. A recent study has shown the anti-obesity activity of ZO and its 
constituents through in vitro and in vivo studies. Consumption of ginger has 
significantly reduced lipid profile and reduce body weight of male Albino rats after 
four weeks of treatment (Mahmoud and Elnour, 2013). Similarly, Misawa et al., 
(2015) have reported the role of ginger extracts in preventing obesity via activation of 
peroxisome proliferator-activated receptor, PPAR-γ pathway in C57BL/6J mice 
treated with dietary ginger extract. In this study, the compound 6-gingerol and 6-
shogaol acted as specific PPAR-γ ligands and stimulated PPAR-γ-dependent gene 
expression in cultured human skeletal muscle myotubes, therefore stimulating fat 
utilization. In another report, 6-gingerol reduced the expression of PPAR-γ associated 
genes and reduced adipogenesis in 3T3-L1 adipocytes (Isa et al., 2008). Obese rats 
treated orally with gingerol for 30 days have shown to reduce body weight and tissue 
lipid suggested ginger supplementation could suppress obesity induced by high-fat diet 
(Saravanan et al., 2014). Ethanol extract of ZZ has reported suppressing body weight 
gain and body fat accumulation by increasing fatty acid oxidation which likely 
mediated via up-regulation of PPAR-α in the liver of high fed diet male Wistar rats 
(Chang et al., 2012). The in vivo and in vitro data does support the potential of ZO and 
ZZ to induce the anti-obesity effect. Therefore, this study was designed to load ZO and 
ZZ extracts into a specific carrier to penetrate into the skin in an attempt to reduced 
localized subcutaneous adipose tissue.  
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The skin barrier is a major limitation for transdermal drug administration. The 
barriers generally designed to keep foreign material out and, in some cases, to allow 
highly regulated transfer of specific desired molecules. Different skin levels such as 
skin surface, epidermis, dermis, and hypodermis lower the chance for penetration of 
drug. Therefore, in drug delivery strategies, various types of carrier for transdermal 
drug delivery have been developed and colloidal vesicle carriers are one of them. The 
modern development of colloidal carriers started with the discovery of liposome. 
These vesicles act as drug reservoir and have the ability to control release rate for drug. 
They also assist the drug to reach the desired pharmacological site of action and have 
continuous duration of action. The other type of colloidal-based carriers is solid lipid 
nanoparticles (SLN) and nanostructured lipid particles (NLC). Prof R. Muller 
discovered SLN in 1995 and the successor of SLN was NLC which developed later in 
1990s (Muller et al., 2007).  SLN were developed to improve the stability issues arise 
from liposome and at the same time retain high absorption and biocompatibility 
properties. NLC is the improvised version of SLN which offers more stable 
nanoparticle and high performance of drug-controlled release. The lipid nanoparticle, 
NLC has nano-size range and its formulation is suitable candidate to encapsulate active 
ingredients and assists in drug delivery to target site. The preparation method of NLC 
significantly influence the physical properties of NLC. The NLC must possess good 
loading capacity and long-term stability to ensure no premature release of drug before 
reaching the target tissue. In another aspect, a smaller size of NLC ensure close contact, 





1.2 Problem Statement 
 
 
There are plenty of products on the shelf claimed to have anti-adiposity effect 
or in a simple word, slimming effect (Stickel, 2007; Phattanawasin et al., 2012). The 
products contain active ingredients such as essential oil and herbs extracts which 
potentially have anti-adiposity influence on human body. However, slimming requires 
reduction in unwanted adipose in subcutaneous tissue under the skin layer. The 
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efficacy studies of topical application for slimming or anti-adiposity product rarely 
focus on the delivery mode of active ingredient into the targeted layer. The data only 
considers the reduction of adipose tissue in subcutaneous layer and theoretically 
assumed that the active ingredient induced lipolysis in fat layer (Kennedy et al., 2015; 
Grosskreutz et al., 2017). The mechanism of carrier penetrating the subcutaneous skin 
layer for lipolysis needs further explanation and scientific proof as many topical 
slimming products claimed possibility to reduce adiposities (Sparavigna et al., 2012). 
The delivery of substance into subcutaneous layer of skin itself is challenging enough 
(Anissimov et al., 2013). The skin is an ultimate barrier against external mechanical, 
chemical, microbial and physical effects. Nevertheless, the large surface area and easy 
accessibility is the main reason for potential application in topical drug delivery. In 
order for a substance to reach into subcutaneous layer of skin, suitable carrier must be 
developed with desirable properties specifically to enhance deeper skin delivery.   
 
 
NLC has been established since 2000 in encapsulation of active ingredients for 
various applications (Pardeike et al., 2009). The nano-scale size, stability, and high 
bioavailability as drug delivery system have made NLC are among preferred carrier 
especially in carrying lipophilic/hydrophobic type of active ingredient (O'Driscoll and 
Griffin, 2008; Das et al., 2012; Khan et al., 2013; Ranpise et al., 2014). Common size 
for nanoparticle for transdermal delivery system is in the range of 50-500 nm. 
Penetration through the skin depends on the particle size of nanoparticles, in which 
larger nanoparticles (>300 nm) will stay on stratum corneum, while smaller 
nanoparticles (<300 nm) will penetrate epidermis and dermis layer of the skin 
(Iannuccelli et al., 2014). However, smaller particle size (20 nm) possessed toxicity to 
the skin compared to larger particle size (Park et al., 2013). Additionally, it may cause 
interaction of nanoparticle with cells, body fluids, and protein. The interaction causes 
biological changes and ability to distribute throughout the body, hence generate 
complexes that are more mobile and can enter tissue sites that normally inaccessible 
(Nel et al., 2006). For instance, smaller particle allows penetration up to the dermis 
layer and causes particle trafficking to regional lymph nodes. Such trafficking can 
deliver particles to paracortical areas in the lymph nodes where macrophage and 
dendritic cells specialized in the uptake of particulate matter. This could lead to the 
effects on the immune system. Although the reticuloendothelial system is able to clear 
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or sequester nanoparticles, self-protein interactions with particles may change their 
antigenicity and initiate autoimmune responses. Therefore, the NLC must be able to 
penetrate into skin by having size of less than 300 nm and must not impose toxicity 
towards cells and tissue.  
 
 
In the search for novel anti-obesity strategies via transdermal penetration for 
ZO and ZZ, the present study was designed to establish the formulation of NLC with 
better skin targeting efficiency, high stability, prolonged release to achieve maximum 
efficacy. The penetration of NLC encapsulated ZO and ZZ into subcutaneous layer 






1.3 Objective of the Research 
 
 
The objective of this research is to formulate Zingiber officinale and Zingiber 
zerumbet oil loaded NLC system which having desirable physical characteristics and 
good stability to penetrate subcutaneous layer of skin hence activate lipolysis in 





1.4 Scopes of the Research 
 
 
In order to achieve the objective, studies have been narrowed down and 




1) Development of an optimized formulation of NLC encapsulated ZO and ZZ 
using hot homogenization and ultrasonication. 
 
2) Characterization of NLC encapsulated ZO and ZZ by morphology, crystalline 
behavior, functional group, and skin penetration analysis, and storage stability 
study. Particle characteristics were measured including particle size, zeta 
potential, and polydispersity index analysis.  
 
3) Determination of kinetic mechanism of active ingredients release from NLC 
using dialysis method. 
 
4) Investigation of the efficacy of NLC encapsulated ZO and ZZ into 
subcutaneous layer of skin to induce lipolysis in adipose tissue, utilizing in 
vitro and in vivo analysis. In vitro study was conducted using 3T3-L1 cells to 
measure lipolysis activity. In vivo studies included in vivo skin deposition and 






1.5 Significance and Original Contributions of the Research 
 
 
This investigation offers several contributions in the area of essential oil 
encapsulation using NLC and its application in transdermal drug delivery which 
focused on subcutaneous skin layer. The contributions are as follows:  
 
 
1) Transdermal delivery of active ingredients can circumvent first pass 
metabolism and maintains the concentration of drug at site of action for longer 
periods. Therefore, an investigation on permeation and release of active 
ingredients onto the targeted side may give useful insight into the 
understanding of NLC’s mechanism of action in vitro and in vivo. In vitro study 
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focuses on the extent of active ingredient diffusion across the skin and the 
ability of lipolytic activity induction on adipocyte cell. The release mechanism 
of active ingredient from nanoparticle is identified according to kinetic release 
profile in the designated experimental condition. In vivo study highlights the 
extent of NLC penetration across rat skin in different treatment duration and 
lipolysis activity detected in plasma level.     
 
2) ZO and ZZ belonged to Zingiberaceae family. It has a wide spectrum of 
traditional uses, as well as biological and pharmacological properties. New 
emerging in vitro data suggest both ZO and ZZ have demonstrated potential 
anti-obesity activity through various mechanisms in vitro and in vivo. NLC has 
been a good candidate for encapsulation ZO and ZZ due to the lipophilicity 
properties and capability to permeate challenging physiological barriers such 





1.6 Thesis Structure and Organization  
 
 
This thesis is divided into five chapters. Chapter 1 covers a brief overview of 
the research background, problems statement, a central objective, scopes of analyses, 
originality and significant contributions of the study. 
 
 
Chapter 2 offer an overview of obesity and topical formulation for fat 
reduction. The literature also highlights the current drug delivery technology available 




Chapter 3 covers the overall methodologies used for optimization of NLC 
encapsulated Zingiber officinale and Zingiber zerumbet, the physical characterization 
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of NLC and in vitro release study of active ingredients. The methodologies of in vitro 
and in vivo penetration of NLC through skin were described in this chapter.  
 
 
Chapter 4 presents the comprehensive results and discussions on the 
optimization of NLC formulation using D-optimal mixture design and the 
characterization including particle size measurement, zeta potential, morphology, 
thermal properties, functional group analysis, in vitro permeation and kinetic of active 
ingredient release from NLC. The in vitro and in vivo analysis were also presented. 
 
 
Chapter 5 provides the overall summary of the research findings and specific 
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